U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06966635) titled 'Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets' on May 04.
Brief Summary: To evaluate whether alkalization has the effect of lowering uric acid and reducing gout flare and determine whether alkalization has a role in the prevention and treatment of urinary calculi in gout, the research participants were divided into the control group, the potassium citrate group and the sodium bicarbonate group. 2 alkalization groups took potassium citrate three times a day 2.16g each time, or sodium bicarbonate three times a day, 1.0g each time, on the basis of the standard uric acid-lowering treatment pl...